Treated – Newsemia

Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan

NewsemiaApril 9, 2020

by NewsemiaApril 9, 202007

AbstractBackground Guidelines recommend targeting systolic blood pressure (SBP) <130 mm Hg in heart failure with preserved ejection fraction (HFpEF) with limited data. Objectives This study sought to determine...

Cardiology

Short-term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan.

NewsemiaApril 3, 2020

by NewsemiaApril 3, 202007

Related Articles Short-term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan. ESC Heart Fail. 2020 Mar 31;: Authors: Mazzetti...

Latest News

Cancer could potentially be treated with new immunotherapy approach, say researchers

NewsemiaMarch 25, 2020

by NewsemiaMarch 25, 202002

Researchers have made a discovery about EGR4 that could instigate a new immunotherapy approach to treating cancer. Source link...

Pharma / Biotech

Oral NAloxone to overcome the moRphine effect in acute COronary syndrome patients treated with TICagrelor – NARCOTIC trial.

NewsemiaMarch 25, 2020

by NewsemiaMarch 25, 2020012

Related Articles Oral NAloxone to overcome the moRphine effect in acute COronary syndrome patients treated with TICagrelor – NARCOTIC trial. Cardiol J. 2020 Mar 24;:...

Neurology

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks

NewsemiaMarch 18, 2020

by NewsemiaMarch 18, 2020032

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal...

Pharma / Biotech

Nivolumab-Ipilimumab Combo Approved to Treat Previously Treated HCC

NewsemiaMarch 13, 2020

by NewsemiaMarch 13, 202006

The FDA granted accelerated approval for the use of nivolumab plus ipilimumab to treat hepatocellular carcinoma in patients who have been treated with sorafenib. Source...

Gastroenterology

FDA approves Opdivo-Yervoy combination for previously treated hepatocellular carcinoma

NewsemiaMarch 11, 2020

by NewsemiaMarch 11, 202003

The FDA granted accelerated approval to nivolumab plus ipilimumab for treatment of patients with hepatocellular carcinoma who previously received sorafenib.The combination is the first dual...

Latest News

Patient‐reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose‐escalation study 1108

NewsemiaMarch 10, 2020

by NewsemiaMarch 10, 2020035

O’Donnell, PH; Arkenau, HT; Sridhar, SS; Ong, M; Drakaki, A; Spira, A; Zhang, J; … Friedlander, T; + view all O’Donnell, PH; Arkenau, HT; Sridhar,...

Gastroenterology

How Is Pancreatitis Treated?

NewsemiaFebruary 28, 2020

by NewsemiaFebruary 28, 202008

Behind the stomach and next to the small intestine is where the pancreas is located. It delivers insulin and glucagon, which like insulin assists the...

Gastroenterology

24 ENDOSCOPIC AND CLINICAL CHARACTERISTICS OF POUCHITIS INVOLVING THE RECTAL CUFF IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED BY PROCTOCOLECTOMY WITH ILEAL POUCH-ANAL ANASTOMOSIS

NewsemiaFebruary 24, 2020

by NewsemiaFebruary 24, 202008

For patients with inflammatory bowel disease (IBD), surgical intervention is sometimes required due to medically refractory colitis or development of neoplasia. Restorative proctocolectomy with ileal...

Gastroenterology

P167 ADULT CROHN’S DISEASE TREATED WITH THE SPECIFIC CARBOHYDRATE DIET (SCD): A CASE REPORT USING OBJECTIVE MARKERS OF RESPONSE

NewsemiaFebruary 21, 2020

by NewsemiaFebruary 21, 202009

The specific carbohydrate diet (SCD) has been shown to resolve symptoms in pediatric IBD patients, inducing clinical remission and normalizing or significantly reducing inflammatory markers....

Neurology

Safety and efficacy of dual antiplatelet pretreatment in patients with ischemic stroke treated with IV thrombolysis: A systematic review and meta-analysis

NewsemiaFebruary 18, 2020

by NewsemiaFebruary 18, 202005

Objective Conflicting data exist on the safety and efficacy of IV thrombolysis (IVT) in patients with acute ischemic stroke (AIS) receiving dual antiplatelet pretreatment (DAPP)....

Latest News

Updated CheckMate -025 Results Show 26% of Patients Treated with Opdivo are Alive at Five Years in Patients with Previously Treated Advanced or Metastatic Renal Cell Carcinoma

NewsemiaFebruary 15, 2020

by NewsemiaFebruary 15, 202009

PRINCETON, N.J.–(BUSINESS WIRE)—- $BMY #BMS–Updated CheckMate -025 Results Show 26% of Patients Treated with Opdivo are Alive at Five Years in Patients with Previously Treated...

Cardiology

DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study.

NewsemiaFebruary 9, 2020

by NewsemiaFebruary 9, 2020014

Related Articles DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study. J Vet Cardiol. 2020...

Latest News

Artificial Sweeteners Help Identify Treated Wastewater Discharged In Local Streams

NewsemiaFebruary 9, 2020

by NewsemiaFebruary 9, 202004

A new study found that 13 percent of wastewater discharged from septic tanks was identified by the presence of artificial sweeteners in rural Southern Ontario....

Neurology

How is ADHD Treated?

NewsemiaFebruary 6, 2020

by NewsemiaFebruary 6, 2020033

These days, it’s common to know someone with attention deficit hyperactivity disorder or ADHD. A friend’s child. Your child’s classmate. A family member. Even an...

Pharma / Biotech

Tumor Time-Course Predicts Overall Survival in Non-Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow-Up Time.

NewsemiaJanuary 29, 2020

by NewsemiaJanuary 29, 2020031

Related Articles Tumor Time-Course Predicts Overall Survival in Non-Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow-Up Time. CPT Pharmacometrics Syst Pharmacol. 2020...

Gastroenterology

1 LOW RISK OF LYMPHOMA IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED USING ANTI-TUMOR NECROSIS FACTOR AGENTS

NewsemiaJanuary 27, 2020

by NewsemiaJanuary 27, 2020038

Anti-Tumor Necrosis Factor (aTNF) agents are among the most effective medications used to treat pediatric inflammatory bowel diseases (pIBD). Despite their effectiveness, concerns regarding an...

Latest News

In vitro response and gene expression of human Retinal Müller cells treated with different Anti-VEGF drugs

NewsemiaJanuary 19, 2020

by NewsemiaJanuary 19, 2020031

Cáceres-Del-Carpio, J; Moustafa, MT; Toledo-Corral, J; Hamid, MA; Atilano, SR; Schneider, K; Fukuhara, PS; … Kuppermann, BD; + view all Cáceres-Del-Carpio, J; Moustafa, MT; Toledo-Corral,...

Cardiology

Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan.

NewsemiaJanuary 16, 2020

by NewsemiaJanuary 16, 2020021

Related Articles Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan. Cardiology. 2020 Jan 15;:1-8 Authors: Díez-Villanueva...